@article{ed86598fa60a4ae99f57026783e2d1d7,
title = "Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: Insights from the BIOSOLVE-IV registry",
author = "Stefan Verheye and Adrian Wlodarczak and Piero Montorsi and Johan Bennett and Jan Torzewski and Michael Haude and Mathias Vrolix and Thomas Buck and Adel Aminian and {Van Der Schaaf}, {Rene J.} and Nuruddin, {Amin Arrif} and Lee, {Michael K.Y.}",
note = "Funding Information: This study was funded by Biotronik AG, B{\"u}lach, Switzerland. Funding Information: S. Verheye reports receiving speaking fees from Alvimedica, Biotronik, and Elixir Medical. M. Haude reports receiving study grants and personal fees from Biotronik, Abbott Vascular, Cardiac Dimensions, and Philips. A. Aminian reports receiving grants from Biotronik. J. Bennett has received research grants and speaking fees from Abbott Vascular and Biotronik AG. The other authors have no conflicts of interest to declare. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = feb,
doi = "10.4244/EIJ-D-18-01058",
language = "English",
volume = "15",
pages = "E1383--E1386",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
number = "15",
}